These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35764030)

  • 21. Vitamin K status, all-cause mortality, and cardiovascular disease in adults with chronic kidney disease: the Chronic Renal Insufficiency Cohort.
    Shea MK; Barger K; Booth SL; Wang J; Feldman HI; Townsend RR; Chen J; Flack J; He J; Jaar BG; Kansal M; Rosas SE; Weiner DE;
    Am J Clin Nutr; 2022 Mar; 115(3):941-948. PubMed ID: 34788785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix Gla protein and the long-term incidence and progression of coronary artery and aortic calcification in the Multi-Ethnic Study of Atherosclerosis.
    Berlot AA; Fu X; Shea MK; Tracy R; Budoff M; Kim RS; Naveed M; Booth SL; Kizer JR; Bortnick AE
    Atherosclerosis; 2024 May; 392():117505. PubMed ID: 38527383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.
    Delanaye P; Krzesinski JM; Warling X; Moonen M; Smelten N; Médart L; Pottel H; Cavalier E
    BMC Nephrol; 2014 Sep; 15():145. PubMed ID: 25190488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Vitamin K Is Inversely Associated with Incident Cardiovascular Disease Risk among Those Treated for Hypertension in the Health, Aging, and Body Composition Study (Health ABC).
    Shea MK; Booth SL; Weiner DE; Brinkley TE; Kanaya AM; Murphy RA; Simonsick EM; Wassel CL; Vermeer C; Kritchevsky SB;
    J Nutr; 2017 May; 147(5):888-895. PubMed ID: 28356433
    [No Abstract]   [Full Text] [Related]  

  • 25. The coincidence of low vitamin K status and high expression of growth differentiation factor 15 may indicate increased mortality risk in stable coronary heart disease patients.
    Mayer O; Bruthans J; Seidlerová J; Karnosová P; Mateřánková M; Gelžinský J; Rychecká M; Opatrný J; Wohlfahrt P; Kučera R; Trefil L; Cífková R; Filipovský J; Vermeer C
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):540-551. PubMed ID: 33257192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women.
    Dalmeijer GW; van der Schouw YT; Vermeer C; Magdeleyns EJ; Schurgers LJ; Beulens JW
    J Nutr Biochem; 2013 Apr; 24(4):624-8. PubMed ID: 22819559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher levels of circulating desphospho-uncarboxylated matrix Gla protein over time are associated with worse survival: the prospective Maastricht Intensive Care COVID cohort.
    Mulder MMG; Schellens J; Sels JEM; van Rosmalen F; Hulshof AM; de Vries F; Segers R; Mihl C; van Mook WNKA; Bast A; Spronk HMH; Henskens YMC; van der Horst ICC; Cate HT; Schurgers LJ; Drent M; van Bussel BCT
    J Intensive Care; 2023 Dec; 11(1):63. PubMed ID: 38111069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin K
    Kristensen JSS; Melholt L; Kristensen KL; Dahl M; Lindholt JS
    Eur J Vasc Endovasc Surg; 2021 Aug; 62(2):267-274. PubMed ID: 33947618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report.
    Schurgers LJ; Barreto DV; Barreto FC; Liabeuf S; Renard C; Magdeleyns EJ; Vermeer C; Choukroun G; Massy ZA
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):568-75. PubMed ID: 20133489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.
    Thamratnopkoon S; Susantitaphong P; Tumkosit M; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S
    Nephron; 2017; 135(3):167-172. PubMed ID: 27951533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population.
    Mayer O; Seidlerová J; Wohlfahrt P; Filipovský J; Vaněk J; Cífková R; Windrichová J; Topolčan O; Knapen MH; Drummen NE; Vermeer C
    J Hum Hypertens; 2016 Jul; 30(7):418-23. PubMed ID: 26016598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desphospho-uncarboxylated matrix Gla protein is a novel circulating biomarker predicting deterioration of renal function in the general population.
    Wei FF; Trenson S; Thijs L; Huang QF; Zhang ZY; Yang WY; Moliterno P; Allegaert K; Boggia J; Janssens S; Verhamme P; Vermeer C; Staessen JA
    Nephrol Dial Transplant; 2018 Jul; 33(7):1122-1128. PubMed ID: 28992263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of kidney transplantation and phosphate binder use in vitamin K status.
    Jansz TT; Neradova A; van Ballegooijen AJ; Verhaar MC; Vervloet MG; Schurgers LJ; van Jaarsveld BC
    PLoS One; 2018; 13(8):e0203157. PubMed ID: 30161193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K
    Aoun M; Makki M; Azar H; Matta H; Chelala DN
    BMC Nephrol; 2017 Jun; 18(1):191. PubMed ID: 28592319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin K Status, Warfarin Use, and Arterial Stiffness in Heart Failure.
    Hashmath Z; Lee J; Gaddam S; Ansari B; Oldland G; Javaid K; Mustafa A; Vasim I; Akers S; Chirinos JA
    Hypertension; 2019 Feb; 73(2):364-370. PubMed ID: 30580682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness.
    Puzantian H; Akers SR; Oldland G; Javaid K; Miller R; Ge Y; Ansari B; Lee J; Suri A; Hasmath Z; Townsend R; Chirinos JA
    Am J Hypertens; 2018 Aug; 31(9):988-994. PubMed ID: 29788226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma Dephosphorylated-Uncarboxylated Matrix Gla-Protein in Systemic Sclerosis Patients: Biomarker Potential for Vascular Calcification and Inflammation.
    Potjewijd J; Tobal R; Boomars KA; van Empel VVPM; de Vries F; Damoiseaux JGMC; Schurgers LJ; van Paassen P
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.
    Schlieper G; Westenfeld R; Krüger T; Cranenburg EC; Magdeleyns EJ; Brandenburg VM; Djuric Z; Damjanovic T; Ketteler M; Vermeer C; Dimkovic N; Floege J; Schurgers LJ
    J Am Soc Nephrol; 2011 Feb; 22(2):387-95. PubMed ID: 21289218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein.
    Dalmeijer GW; van der Schouw YT; Magdeleyns E; Ahmed N; Vermeer C; Beulens JW
    Atherosclerosis; 2012 Dec; 225(2):397-402. PubMed ID: 23062766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults.
    Shea MK; O'Donnell CJ; Vermeer C; Magdeleyns EJ; Crosier MD; Gundberg CM; Ordovas JM; Kritchevsky SB; Booth SL
    J Nutr; 2011 Aug; 141(8):1529-34. PubMed ID: 21628633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.